Scientia Pharmaceutica Events Announce Your Event Here
7–9 February 2019 Innovate NanoMedicine 2019 (INMC 2019)
Hilton Americas – Houston
12–15 November 2018 World ADC San Diego 2018
San Diego, USA
World ADC San Diego is the industry’s longest standing and most comprehensive antibody-drug conjugate conference.
Across multiple-streams of learning, World ADC will cover every element of ADC drug development from construct design to improving preclinical predictability and product manufacturability. This leading antibody-drug conjugate event will provide you with an unparalleled breadth and depth of content.
Don’t miss this opportunity to join your fellow scientists at the heart of the ADC community. Join 650+ of your peers, from 220 organizations for your most valuable ADC learning and networking opportunity of 2018.
26–28 September 2018 International Conference On Nanomedicine And Nanobiotechnology 2018 (ICONAN 2018)
The International Conference On Nanomedicine And Nanobiotechnology is an annual event that hosts high-profile plenary speakers, world-class researchers, oral and poster presentations, workshops, sponsor exhibits and afterworks. It is a great opportunity to share your research findings with a wide audience, promote knowledge exchange, and network.
Targeted drug delivery, organ biodistribution and nanocarriers
Nanomedicine for immune system and cancer diagnosis & therapy
Biological & medical nanodevices and biosensors
3D models, tissue engineering and regenerative nanomedicine
Toxicology and risk assessment of nanomedicine systems
Nano-Imaging for diagnosis, therapy and delivery in preclinical and clinical fields
Nano and microsystems for artificial biology and biocatalysis
Nanotechnology and translational medicine: from the bench to the bedside
Prof. Margherita Morpurgo (Chair), Padova University, Italy
Dr. Paolo Bigini (Chair), Mario Negri Institute for Pharmacological Research, Italy
Prof. Vicki Stone, Heriot-Watt University, UK
Prof. Rainer Haag, Institut für Chemie und Biochemie, Freie Universität Berlin, Germany
Anton Ussi, EATRIS, Netherlands
Prof. Sophia Antimisiaris, Institute of Chemical Engineering FORTH/ICE-HT & University of Patras, Greece
Prof. Francesco Stellacci, EPFL, Switzerland
Prof. Luisa De Cola, University of Strasbourg, France
Prof. Silvio Aime, University of Turin, Italy
Prof. Rabah Boukherroub, Lille 1 University, France
Dr. Xiaoyuan Chen, National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH, U.S.A.
Prof. Albert Van Den Berg, University of Twente, The Netherlands
Submission: June 27, 2018
Registration: July 27, 2018
27–28 June 2018 World ADC Asia 2018
Focused on ADC drug development, World ADC Asia will enable you to propel your antibody-drug conjugate pipeline into clinical development. Join 80+ ADC experts from the world’s leading ADC companies to network with potential collaborators and cement existing partnerships.
Designed with AbGenomics, Roche and RemeGen and other leading ADC organisations this forum will enable you to explore novel linker technologies for enhanced in vivo stability, confidently meet regulatory quality specifications for biosimilar candidates and confidently outsource to your chosen CMO.
This is the only ADC focused conference that will bring together all the key players both from within Asia, the US and Europe.